Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.

Elastic Net DNA methylation clocks are inaccurate for predicting age and health status; a "noise barometer" may better indicate aging and disease.

PCOS may increase the risk of certain cancers.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

A group has developed therapies that show promise for treating cancer and various other conditions.

High TSPEAR levels in colorectal cancer predict worse outcomes.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

WWOX deficiency in mice causes skin and fat tissue problems due to disrupted cell survival signals.

Adding a second method to PROTACs could improve cancer treatment.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Plumbagin may help protect cells, reduce inflammation, and has potential for treating various diseases, but more research is needed.